www.pierre-fabre.com
Introduction
Experts
Recommendations
Session 1
Session 2
Session 3
Session 4
Thanks
Contacts
Appendices
Search
 
» FIBROMYALGIA 4 » Introduction Imprimer la page

Fibromyalgia: Assessment and Outcome


Introduction


Richard Gracely

Ann Arbor - USA


Michael Späth

Munich - Germany

Fibromyalgia is a prevalent health and social problem and a growing economic burden. The number of clinical trials evaluating both pharmacological and non-pharmacological treatments has increased recently. Most of these trials use the American College of Rheumatology (ACR) criteria as the basic inclusion criterion for the classification of fibromyalgia. The ACR criteria do not cover the whole spectrum of fibromyalgia complaints and findings, but they are accepted as the “gold standard” for clinical research and clinical trials. A more complete set of assessment and outcome measurement tools would greatly facilitate diagnosis and evaluation of treatments in both research and clinical care settings. Several expert groups are working on this topic.

The fourth in a series of “Les Entretiens du Carla” meetings, dedicated to all different aspects of fibromyalgia, addressed outcome and assessment measures. The group employed a Delphi-like process to determine the need for a hierarchy of assessment tools to be used for diagnosis, selection of treatment and evaluation of treatment efficacy. The recommendations presented here are the result of this Delphi process. Similar to the criteria dilemma: We need the tools for getting the results, which then may validate the tools.

We are just at the beginning of this long and challenging process of selection and validation. Ultimately, researchers, clinicians and patients will be able to use well-evaluated tools to guide diagnosis and treatment. As in recent years, the results of the “Entretiens” will be presented during a symposium at the annual EULAR congress in Barcelona. Pierre Fabre Médicament deserves many thanks for enabling and supporting these stimulating meetings, which always lead to exciting new research ideas and projects.

From left to right and top to bottom:
Thomas Weiss Marcel-Francis Kahn Henning Bliddal David A. Williams Jean-Paul Caubère Bernard Auvinet Francis Blotman Patrick Cherin Jennifer Glass Anne Cazorla Florence Gaudoux Jorge Alberto Costa e Silva Yves Mainguy Eva Kosek Étienne André Olivier Vitton Jon Russell Dominique Crouzit Philip Mease Jacky Brunet Michael Späth Juan Enrique Mezzich Richard Gracely Dan Buskila Bente Danneskiold-Samsøe Harvey Moldofsky

Haut de page